133 related articles for article (PubMed ID: 30142120)
21. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients.
Kubota K; Kamisawa T; Okazaki K; Kawa S; Hirano K; Hirooka Y; Uchida K; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Shimosegawa T; Takeyama Y; Chiba T
J Gastroenterol; 2017 Aug; 52(8):955-964. PubMed ID: 28062947
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment.
Manfredi R; Graziani R; Cicero C; Frulloni L; Carbognin G; Mantovani W; Mucelli RP
Radiology; 2008 May; 247(2):435-43. PubMed ID: 18430876
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of autoimmune pancreatitis.
Kamisawa T; Okamoto A
J Gastroenterol; 2007 May; 42 Suppl 18():59-62. PubMed ID: 17520225
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
Miyazawa M; Takatori H; Shimakami T; Kawaguchi K; Kitamura K; Arai K; Matsuda K; Sanada T; Urabe T; Inamura K; Kagaya T; Mizuno H; Fuchizaki U; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
PLoS One; 2017; 12(11):e0188549. PubMed ID: 29166415
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study.
Sugimoto M; Takagi T; Suzuki R; Konno N; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Asama H; Takasumi M; Hikichi T; Watanabe H; Obara K; Ohira H
PLoS One; 2015; 10(9):e0138604. PubMed ID: 26381760
[TBL] [Abstract][Full Text] [Related]
26. [The long-term follow-up results after steroid treatment in patients with autoimmune chronic pancreatitis].
Choi EK; Kim MH; Kim JC; Han J; Oh SI; Jeong WJ; Jeong JY; Lee SS; Seo DW; Lee SK
Korean J Gastroenterol; 2006 Jun; 47(6):440-8. PubMed ID: 16809951
[TBL] [Abstract][Full Text] [Related]
27. Pancreaticobiliary involvement in treated type 1 autoimmune pancreatitis: Imaging pattern and risk factors for disease relapse.
Zhu L; Xue HD; Zhang W; Wang Q; Tan B; Lai YM; Zheng WY; Asbach P; Hamm B; Denecke T; Jin ZY
Eur J Radiol; 2019 Nov; 120():108673. PubMed ID: 31550640
[TBL] [Abstract][Full Text] [Related]
28. Relative Rise of Serum IgG4 Levels After Steroid Therapy for Autoimmune Pancreatitis Predicts the Likelihood of Relapse.
Suzuki D; Shimizu K; Tokushige K
Pancreas; 2018 Apr; 47(4):412-417. PubMed ID: 29517627
[TBL] [Abstract][Full Text] [Related]
29. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis.
Tomiyama T; Uchida K; Matsushita M; Ikeura T; Fukui T; Takaoka M; Nishio A; Okazaki K
J Gastroenterol; 2011 May; 46(5):696-704. PubMed ID: 21188426
[TBL] [Abstract][Full Text] [Related]
30. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study.
Kamisawa T; Yoshiike M; Egawa N; Nakajima H; Tsuruta K; Okamoto A
Pancreatology; 2005; 5(2-3):234-8; discussion 238-40. PubMed ID: 15855821
[TBL] [Abstract][Full Text] [Related]
31. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis.
Park DH; Kim MH; Oh HB; Kwon OJ; Choi YJ; Lee SS; Lee TY; Seo DW; Lee SK
Gastroenterology; 2008 Feb; 134(2):440-6. PubMed ID: 18155707
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: A multi-centre study.
López-Serrano A; Crespo J; Pascual I; Salord S; Bolado F; Del-Pozo-García AJ; Ilzarbe L; de-Madaria E; Moreno-Osset E;
Pancreatology; 2016; 16(3):382-90. PubMed ID: 26944001
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
[TBL] [Abstract][Full Text] [Related]
34. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan.
Ito T; Nishimori I; Inoue N; Kawabe K; Gibo J; Arita Y; Okazaki K; Takayanagi R; Otsuki M
J Gastroenterol; 2007 May; 42 Suppl 18():50-8. PubMed ID: 17520224
[TBL] [Abstract][Full Text] [Related]
35. Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis.
Buijs J; van Heerde MJ; Rauws EA; de Buy Wenniger LJ; Hansen BE; Biermann K; Verheij J; Vleggaar FP; Brink MA; Beuers UH; Kuipers EJ; Bruno MJ; van Buuren HR
Pancreas; 2014 Mar; 43(2):261-7. PubMed ID: 24518506
[TBL] [Abstract][Full Text] [Related]
36. Incidence and outcome of lung involvement in IgG4-related autoimmune pancreatitis.
Ogoshi T; Kido T; Yatera K; Oda K; Nishida C; Yamasaki K; Orihashi T; Kawanami Y; Ishimoto H; Taguchi M; Harada M; Mukae H
Respirology; 2015 Oct; 20(7):1142-4. PubMed ID: 26182953
[TBL] [Abstract][Full Text] [Related]
37. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment.
Hirano K; Tada M; Isayama H; Yagioka H; Sasaki T; Kogure H; Nakai Y; Sasahira N; Tsujino T; Yoshida H; Kawabe T; Omata M
Gut; 2007 Dec; 56(12):1719-24. PubMed ID: 17525092
[TBL] [Abstract][Full Text] [Related]
38. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.
Kim HM; Chung MJ; Chung JB
Pancreas; 2010 Jul; 39(5):555-60. PubMed ID: 20182397
[TBL] [Abstract][Full Text] [Related]
39. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
[TBL] [Abstract][Full Text] [Related]
40. Management strategies for autoimmune pancreatitis.
Kamisawa T; Takuma K; Hara S; Tabata T; Kuruma S; Inaba Y; Gopalakrishna R; Egawa N; Itokawa F; Itoi T
Expert Opin Pharmacother; 2011 Oct; 12(14):2149-59. PubMed ID: 21711086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
